SIRT1/IGFBPrP1/TGF β1 axis involved in cucurbitacin B ameliorating concanavalin A‐induced mice liver fibrosis-Reference-Cited by-同舟云学术

SIRT1/IGFBPrP1/TGF β1 axis involved in cucurbitacin B ameliorating concanavalin A‐induced mice liver fibrosis

Published:2020-06-15 Issue:5 Volume:127 Page:371-379
ISSN:1742-7835
Container-title:Basic & Clinical Pharmacology & Toxicology
language:en
Short-container-title:Basic Clin Pharmacol Toxicol

Author:

Yang Li¹^ORCID,Ao Qinfang²,Zhong Qingmei³,Li Wen⁴,Li Wenhong⁵

Affiliation:

1. Department of Pharmacy The Ninth Hospital of Nanchang Nanchang China

2. Clinical Laboratory The Ninth Hospital of Nanchang Nanchang China

3. Department of Pathology The Ninth Hospital of Nanchang Nanchang China

4. Viral Hepatitis/Liver Failure Laboratory The Ninth Hospital of Nanchang Nanchang China

5. Faculty of Pharmaceutical Sciences Jiangxi University of Traditional Chinese Medicine Nanchang China

Publisher

Wiley

Subject

Pharmacology,Toxicology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcpt.13446

Reference32 articles.

1. Regression of Liver Fibrosis

2. Liver Cirrhosis Mortality in Europe, with Special Attention to Central and Eastern Europe

3. Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest)

4. Antifibrotic Therapies: Will We Ever Get There?

5. Search for a novel antioxidant, anti‐inflammatory/analgesic or anti‐proliferative drug: Cucurbitacins hold the ace;Bernard SA;J Med Plants Res,2010

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multicomponent phytopharmaceutical Dipana for the treatment of hepatobiliary disorders. A review;Consilium Medicum;2024-08-05

2. Exploring the effect and mechanism of cucurbitacin B on cholestatic liver injury based on network pharmacology and experimental verification;Journal of Ethnopharmacology;2024-03

3. Sirt1 Inhibits Atrial Fibrosis by Downregulating the Expression of the Transforming Growth Factor-f31/Smad Pathway;ACTA CARDIOL SIN;2024

4. Total cucurbitacins from Herpetospermum pedunculosum pericarp do better than Hu-lu-su-pian (HLSP) in its safety and hepatoprotective efficacy;Frontiers in Pharmacology;2024-02-22

5. Cucurbitacin B ameliorates AKT-driven fatty liver disease in mice by suppressing AKT/mTORC1 and LXRα/SREBP1 lipogenic pathways;Journal of Functional Foods;2024-02